CFDA: Yet another story? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-12 13:09 (2001 d 22:19 ago) – Posting: # 18887
Views: 6,058

Hi Helmut,

thanks for your help.

CFDA has relased the draft guidance for HVBE, which follows FDA method (RSABE).

I still have a question about EMA method. Do you mean if we follow EMA's guidance, the ABEL should be used rather than RSABE, please give me more advise.

thanks in advance. :-D:-D:-D

Complete thread:

UA Flag
Activity
 Admin contact
22,811 posts in 4,783 threads, 1,639 registered users;
26 visitors (0 registered, 26 guests [including 8 identified bots]).
Forum time: 10:29 CET (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5